[go: up one dir, main page]

HUP9900045A3 - Improved leukaemic blood-based product and their use in therapy - Google Patents

Improved leukaemic blood-based product and their use in therapy

Info

Publication number
HUP9900045A3
HUP9900045A3 HU9900045A HUP9900045A HUP9900045A3 HU P9900045 A3 HUP9900045 A3 HU P9900045A3 HU 9900045 A HU9900045 A HU 9900045A HU P9900045 A HUP9900045 A HU P9900045A HU P9900045 A3 HUP9900045 A3 HU P9900045A3
Authority
HU
Hungary
Prior art keywords
leukaemic
therapy
blood
improved
based product
Prior art date
Application number
HU9900045A
Other languages
Hungarian (hu)
Original Assignee
Martyn Robertne Goeroeg Jolan
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Martyn Robertne Goeroeg Jolan filed Critical Martyn Robertne Goeroeg Jolan
Priority to HU9900045A priority Critical patent/HUP9900045A3/en
Publication of HU9900045D0 publication Critical patent/HU9900045D0/en
Priority to PCT/HU2000/000002 priority patent/WO2000040256A1/en
Priority to AU21225/00A priority patent/AU2122500A/en
Publication of HUP9900045A2 publication Critical patent/HUP9900045A2/en
Publication of HUP9900045A3 publication Critical patent/HUP9900045A3/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/14—Blood; Artificial blood
    • A61K35/16—Blood plasma; Blood serum
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Cell Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Hematology (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Virology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
HU9900045A 1999-01-08 1999-01-08 Improved leukaemic blood-based product and their use in therapy HUP9900045A3 (en)

Priority Applications (3)

Application Number Priority Date Filing Date Title
HU9900045A HUP9900045A3 (en) 1999-01-08 1999-01-08 Improved leukaemic blood-based product and their use in therapy
PCT/HU2000/000002 WO2000040256A1 (en) 1999-01-08 2000-01-07 Pharmaceutical composition based on blood drawn from leukemia patients
AU21225/00A AU2122500A (en) 1999-01-08 2000-01-07 Pharmaceutical composition based on blood drawn from leukemia patients

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
HU9900045A HUP9900045A3 (en) 1999-01-08 1999-01-08 Improved leukaemic blood-based product and their use in therapy

Publications (3)

Publication Number Publication Date
HU9900045D0 HU9900045D0 (en) 1999-03-29
HUP9900045A2 HUP9900045A2 (en) 2000-12-28
HUP9900045A3 true HUP9900045A3 (en) 2001-02-28

Family

ID=89997645

Family Applications (1)

Application Number Title Priority Date Filing Date
HU9900045A HUP9900045A3 (en) 1999-01-08 1999-01-08 Improved leukaemic blood-based product and their use in therapy

Country Status (3)

Country Link
AU (1) AU2122500A (en)
HU (1) HUP9900045A3 (en)
WO (1) WO2000040256A1 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HUP0002597A2 (en) * 2000-07-10 2003-01-28 András Bertha Pharmaceutical composition for treatment and diagnosticate mainly tumorous illnesses and process for producing lipid free fraction of blood plasma
HUP0200172A2 (en) 2002-01-15 2003-11-28 András Bertha Process for extracting an antitumor active ingredient

Also Published As

Publication number Publication date
AU2122500A (en) 2000-07-24
WO2000040256A1 (en) 2000-07-13
HU9900045D0 (en) 1999-03-29
HUP9900045A2 (en) 2000-12-28

Similar Documents

Publication Publication Date Title
AU9619301A (en) 2-, 3-, 4-, or 5-substituted-n1-(benzensulfonyl)indoles and their use in therapy
GB9721437D0 (en) Heteroaromatic compounds and their use in medicine
IL156678A0 (en) Glucopyranosyloxypyrazole derivatives and use thereof in medicines
AU2001293553A1 (en) Phosphatidylserine-carrying apoptosis-mimicking bodies and the use thereof in medical treatment
IL149496A0 (en) Pharmaceutical combinations and their use in treating gastrointestinal disorders
PL352330A1 (en) Derivatives of pyridopyranoazepine, making of same and use of same in therapy
HUP0400069A3 (en) Pharmaceutical combinations and their use in preventing and treating the thrombosis
HUP0203811A3 (en) Use of polymeric material in the treatment of hard surfaces
AU2001266229A1 (en) Hcn polypeptides and polynucleotides and their use in therapy
PL347542A1 (en) Therapeutic product and its use
ZA983740B (en) Novel amidine derivatives and their use in therapy
HU9900045D0 (en) Improved leukaemic blood-based product and their use in therapy
PL338123A1 (en) 6-pyrrolydin-2-ylpyridines, their production and application in therapy
EP1154783A4 (en) Medicaments comprising relaxin and their use
EP1224939A4 (en) Interferon complex and medicinal use thereof
GB9903919D0 (en) Aminophenols and their therapeutic use
GB9929581D0 (en) Comjpositions and their use
GB0026428D0 (en) Hydroimidazolone derivatives and their use in therapy
GB9818018D0 (en) Microparticles and their use in therapy
GB9826539D0 (en) Therapeutic product and its use
GB9826535D0 (en) Therapeutic product and its use
GB9826536D0 (en) Therapeutic product and its use
GB9826537D0 (en) Therapeutic product and its use
GB0015676D0 (en) Aryl compounds their preparation and their use in therapy
GB9905307D0 (en) Therapy and use of compounds in therapy